This article, written byKatharine Sedivy-Haley, University of British Columbia, originally appeared on The Conversation and is republished here with permission: When I was applying to graduate school in 2012, it felt like stem cells were about to revolutionize medicine.
Salk Institute researchers have used of a state-of-the-art technology known as single-nucleus (sn) assay for transposase-accessible chromatin (ATAC) sequencing (snATAC-seq) to profile how specific types of mammary cells differentiate during development.
Anti-cancer therapies aimed at blocking mitochondrial energy generation may have wider effects on cancer cell behaviour than just preventing proliferation, new Cambridge research into brain development and tumours in the fruit fly suggests. Cancer cells were once thought to rely on sugar as the primary fuel for their growth, a phenomenon known as the Warburg effect. More recently, it has become clear that other energy sources may be equally important, and much of the growth in cancer cells is fuelled by mitochondria, the powerhouses of cells.
A newly designed viral vector the vehicle that delivers a gene therapyto a patients cells for use insickle cell anemia is more efficient than earlier vectors at introducing healthy copies of genes into stem cells and can be produced in greater amounts, studies in animal models show.
Carolyn Dundes came to Stanford Medicine to learn about brain development and stem cell biology, not to be a spokesperson for gender minorities.
Image caption Caroline Wyatt visited Prof Robin Franklin to find out more about a drug that might help stop the progression of MS "I don't like to think of the future. It's such a big question mark
DUBLIN--(BUSINESS WIRE)--The "3D Bioprinting Market by Component (3D Bioprinters (Microextrusion, Inkjet, Laser), Bioink (Natural, Synthetic, Hybrid)), Material (Hydrogel, Living Cells), Application (Skin, Drug Research), End user (Biopharma, Academia) - Global Forecast to 2024" report has been added to ResearchAndMarkets.com's offering. The 3D bioprinting market is projected to reach USD 1,647 million by 2024 from USD 651 million in 2019, at a CAGR of 20.4% from 2019 to 2024. The growth in this market is mainly driven by technological advancements in 3D bioprinters and biomaterials, increasing the use of 3D bioprinting in the pharmaceutical and cosmetology industries, and rising public and private funding to support bioprinting research activities
Cell culture is a complex procedure in which cells are grown under controlled physical conditions outside the natural environment. These cells are used to develop model systems for research, study of cellular structure and functions, stem cell research, drug discovery and genetic engineering.
The Progress 1000 is compiled every year.
Recent Comments